ArticleInternational journal of clinical oncology2009

Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer.

Osamu Ishimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.